Papers: 28 Nov 2014 - 5 Dec 2014
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
Targeted GAS6 Delivery to the CNS Protects Axons from Damage during Experimental Autoimmune Encephalomyelitis.
Levels of mRNA for dopaminergic receptor D5 in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis.
Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis.
Antibody patterns vary arbitrarily between cerebrospinal fluid and aqueous humor of the individual multiple sclerosis patient: Specificity-independent pathological B cell function.
Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis.
Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970¿2010.
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
17β-trenbolone, an anabolic-androgenic steroid as well as an environmental hormone, contributes to neurodegeneration.
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis.
Moxibustion for Asthma, Acupuncture for Epilepsy, Psychological Therapies for Irritable Bowel Syndrome, Exercise Training for Multiple Sclerosis, and Comfrey Root for Acute Back Pain.
IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy.
The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
Consistency in Administration and Response for the Backward Push and Release Test: A Clinical Assessment of Postural Responses.
A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human glia.
The level of viral infection of antigen-presenting cells is critical for the development of TMEV-induced demyelinating disease.
Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease.
Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases.
EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-κB Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells.
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
Bioconcentration, metabolism and neurotoxicity of the organophorous flame retardant 1,3-dichloro 2-propyl phosphate (TDCPP) to zebrafish.